Macherey-Nagel

Duren, Germany Founded: 1984 • Age: 42 yrs
Provider of water analysis, chromatography, rapid testing, and bioanalytical products

About Macherey-Nagel

Macherey-Nagel is a company based in Duren (Germany) founded in 1984. Macherey-Nagel offers products and services including Filtration Filters, pH Test Strips, and Water Analysis Kits. Macherey-Nagel operates in a competitive market with competitors including Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.

  • Headquarter Duren, Germany
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website mn-net.com
  • Social LinkedIn X Facebook YouTube
  • Legal Name Macherey-Nagel Gmbh & Co. Kg
Key Metrics

Products & Services of Macherey-Nagel

Macherey-Nagel offers a comprehensive portfolio of products and services, including Filtration Filters, pH Test Strips, and Water Analysis Kits.

Filtration Filters
Filtration

Laboratory filters for sample preparation and purification processes

pH Test Strips
Rapid Tests

Strips for accurate pH measurement in scientific and industrial applications

Water Analysis Kits
Water Analysis

Kits for testing water quality and parameters in environmental monitoring

Apps and channels of Macherey-Nagel

its YouTube channel MACHEREY-NAGEL has 1.03K subscribers and 30 videos.

MACHEREY-NAGEL
YouTube 1.03K subscribers 30 videos Howto & Style
Open channel

Videos from Macherey-Nagel

The most watched videos on Macherey-Nagel's YouTube channel, MACHEREY-NAGEL (1.03K subscribers). Click a video to play it here.

HPLC analysis of drugs according to pharmacopoeia
3.8K views
Compact photometer PF-12Plus - Get started
3.2K views
RNA purification with MN – NucleoSpin® RNA and NucleoSpin® RNA Plus
2.7K views
How to perform NANOCOLOR COD tube tests
2.6K views

More on MACHEREY-NAGEL.

Funding Insights of Macherey-Nagel

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of Macherey-Nagel with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2014–Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in Macherey-Nagel

Macherey-Nagel has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for Macherey-Nagel

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Macherey-Nagel

2 dated milestones of Macherey-Nagel across 30 years, from founding to its latest funding, stage changes and deals.

  1. Founded Macherey-Nagel is founded.
  2. Funding First funding round.

Competitors of Macherey-Nagel

Macherey-Nagel operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
abcam.com1998Cambridge, United Kingdom$78.8M405
Biological reagents and antibodies are developed for life science research.
stemcell.com1993Vancouver, Canada$11.92M129
Developer of cell culture media and ancillary reagents for life science research
genscript.com2002Piscataway, United States$15M5,260
Reagents and instruments are provided for life sciences research.
sinobiological.com2007Beijing, China$29.41M–
Reagents and kits are provided for clinical research applications.
miltenyibiotec.com1989Bergisch Gladbach, Germany–585
Develops tools and products for research and clinical application
devyser.com2004Stockholm, Sweden$15.48M–
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
exonhit.com1997Paris, France$65.46M–
Fully integrated in vitro diagnostics company specializing in transplantation, infectious diseases and cancer diagnosis
origene.com1996Rockville, United States$69.55M141
Proteins, antibodies, and molecular tools are manufactured for research applications.
sangon.com2003Shanghai, China$300M–
Research services, reagents, and kits for biotech applications are provided.
meridianbioscience.com1976Ohio, United States––
Molecular diagnostic device and kits
Premium access

Detailed competitors of Macherey-Nagel

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Macherey-Nagel

The website of Macherey-Nagel (mn-net.com) receives about 156.3K visits a month.

  • Monthly visits
    156.3K

    ▲ 20.1% vs previous month

Similar websites

Websites whose visitors overlap most with Macherey-Nagel. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
boeco.com
100%
–#10,745,030View details
kruess.com
100%
17.5K#1,498,746View details
velp.com
100%
75.1K#508,768View details
labstellar.de
labstellar.de
94%
–#2,263,339–
elementlabsolutions.com
elementlabsolutions.com
93%
–#853,636–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for Macherey-Nagel

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Macherey-Nagel

Premium access

Complete news archive for Macherey-Nagel

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Macherey-Nagel

10 companies that operate in the same segment as Macherey-Nagel (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M2,020
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 3.22 BUSD 147.17 M1,000
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
2006Sunnyvale, California, United StatesUSD 943.53 MUSD 189.9 M265
Provider of DNA testing services to create a family tree and ancestor
2003Yehud, Central District, IsraelUSD 40 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Gene therapies for rare diseases including retinal dystrophies are developed.
2013Philadelphia, Pennsylvania, United StatesUSD 82.8 MUSD 64.73 M822
Therapeutics for genetic diseases are developed through targeted interventions.
2015Palo Alto, California, United StatesUSD 434.2 MUSD 502.08 M730
Provider of an online genealogy platform offering a host of services
1996Lehi, Utah, United StatesUSD 146.2 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Macherey-Nagel

Macherey-Nagel was founded in 1984 and raised its 1st funding round 30 years after it was founded.

Macherey-Nagel is headquartered in Duren, Germany. It is registered at Duren, North Rhine-westphalia, Germany.

Macherey-Nagel was founded in 1984 and is headquartered in Duren, Germany. Analytical products are developed and distributed for laboratory applications in water testing, chromatography, and bioanalysis. The portfolio encompasses filtration items like syringe filters and membranes, rapid test strips for ions and urine, colorimetric kits for water quality, and purification tools for DNA, RNA, and proteins. Operations serve research, environmental, and industrial sectors across Europe and beyond.

Macherey-Nagel's top competitors include Abcam, Sino Biological and Meridian Bioscience.

Macherey-Nagel offers Filtration Filters, pH Test Strips, and Water Analysis Kits.

Macherey-Nagel has 1 investor. Key investors include European Union.

Macherey-Nagel operates through Macherey-Nagel Gmbh & Co. Kg.

The website of Macherey-Nagel receives about 156 thousand visits a month.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available